Common Contracts
3 similar Securities Purchase Agreement contracts by Comera Life Sciences Holdings, Inc., H-Cyte, Inc.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 29th, 2023 • Comera Life Sciences Holdings, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 29, 2023, between Comera Life Sciences Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 29th, 2023 • Comera Life Sciences Holdings, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 29, 2023, between Comera Life Sciences Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 21st, 2019 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Florida
This Securities Purchase Agreement (this “Agreement”) is dated as of November 15, 2019, by and among H-Cyte, Inc., a Nevada corporation (the “Company”) and the purchasers identified on the signature pages hereto (including any successors and assigns, the “Purchaser(s)”).
